clene.com - CLNN Forvard P/S multiplikatori
Clene Inc. o'zining nanoterapevtik platformalarini kengaytirmoqda, bunda sinovlarni yakunlash va strategik hamkorlarni jalb qilishni maqsad qilgan. Bashorat qilingan P/S ko'rsatkichi ushbu kutishlarning bozor qiymatini namoyish etadi, bunda 234.60 qiymati metrikaning muvozanatini aks ettiradi. Biznes asosi neyrodegeneratsiyaga qarshi kurashish uchun oltin nanoparticles patentlaridan iborat bo'lib, dori sintezi avtomatlashtirilgan algoritmlar yordamida optimallashtirilgan.
clene.com (CLNN) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- bozor narxi va tahlilchilarning maqsadli narxlari:
- emitentning bozor qiymati haqida ma'lumotlar:
- emitentning balans qiymati statistikasi:
- qarzdorlik darajasi va moliyaviy likvidlik ma'lumotlari:
Qarzning xususiy kapitalga nisbati Clene Inc.|CLNN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Clene|CLNN - Kompaniyaning jamlangan qarzi|Qarzning balans kapitallashuviga nisbati Clene Inc.|CLNN - Kompaniyaning uzoq muddatli qarzdorligi|Kompaniyaning qisqa muddatli qarzi Clene|Tezkor likvidlik koeffitsiyenti clene.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
CLNN - Kompaniyaning sof daromadi|Kelajakdagi foyda Clene Inc.|CLNN - P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Clene|CLNN - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Clene Inc.|CLNN - Foizlar, soliqlar va eskirishdan oldingi foyda|Bir aksiya uchun sof foyda (EPS TTM) Clene|CLNN - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi clene.com|CLNN - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Clene Inc.
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning fundamental baholanishi:CLNN (Clene Nanomedicine)
Clene Inc. (CLNN) kompaniyasining biotexnologiya sektori uchun, bunda baholash miqyosi miya terapiyasidagi kvant nanokatalizatorlarining salohiyati bilan belgilanadi, forward P/S metriki bozorning tushumlar bo'yicha kutganlarini aniqlovchi asosiy ko'rsatkich bo'lib xizmat qiladi. U joriy bozor kapitalizatsiyasini konsensus savdo prognozi bilan solishtiradi, bu esa investorlarga ushbu forward P/S metrikasini tahlil qilishda innovatsiya qiymatining fundamental qayta baholanishini qisqa muddatli narxlar tebranishlaridan ajratish imkonini beradi.
Clene Inc. raqobatchilari tahlili
Narxning prognoz qilingan daromadga nisbati Biogen BIIB|NBIX: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Regencell - Forvard P/S multiplikatori|Axsome Corp (AXSM) - Forvard narx/daromad multiplikatori|ACAD (ACADIA Pharmaceuticals) - Forvard narx/daromad multiplikatori|XENE - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|VKTX (Viking Therapeutics, Inc.) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Supernus Pharmaceuticals, Inc. (SUPN)|Narxning prognoz qilingan daromadga nisbati Catalyst Pharmaceuticals Inc (CPRX)|Narxning prognoz qilingan daromadga nisbati DNLI (Denali Corp)|Narxning prognoz qilingan daromadga nisbati Harmony Biosciences HRMY|BHVN: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|AMLX - Narxning prognoz qilingan daromadga nisbati|TRVI (Trevi Therapeutics Inc) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Praxis Medicines (PRAX) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati AVXL|CBLL (CeriBell, Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Prothena Corporation PRTA|Forvard narx/daromad multiplikatori ALEC (Alector, Inc.)|Forvard P/S multiplikatori Annexon Biosciences (ANNX)|Narxning prognoz qilingan daromadga nisbati Omeros OMER|Sotuvga nisbatan forvard narx NGNE|ACIU - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati voyagertherapeutics.com|NMRA: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Scilex Holding|Narxning prognoz qilingan daromadga nisbati Tevogen Bio Holdings, Inc.|Narxning prognoz qilingan daromadga nisbati ACOG|Forvard P/S multiplikatori CGTX|IKT - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Cassava Sciences SAVA|ASRT: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Coya - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Vistagen Therapeutics|OVID (ovidrx.com) - Forvard narx/daromad multiplikatori|acumenpharm.com - Sotuvga nisbatan forvard narx|CRVO (CervoMed) - Forvard P/S multiplikatori|Alterity Therapeutics Ltd (ATHE) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati PepGen Inc. (PEPG)|Jupiter Neurosciences, Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori RLMD (Relmada Therapeutics)|ANVS - Forvard narx/daromad multiplikatori|GRCE: Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Firefly Neuroscience, Inc. AIFF|KLTO: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori NeuroSense Therapeutics Ltd.|Narxning prognoz qilingan daromadga nisbati Reviva Pharmaceuticals|Narxning prognoz qilingan daromadga nisbati MTVA|Narxning prognoz qilingan daromadga nisbati NeurAxis (NRXS)|heliusmedical.com - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Passage Bio PASG|NEUP: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|NERV - Narxning prognoz qilingan daromadga nisbati|ATHA (athira.com) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ADXN: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alzamend Neuro (ALZN)|Forvard narx/daromad multiplikatori CYCN|Forvard P/S multiplikatori Protagenic|Narxning prognoz qilingan daromadga nisbati Pasithea Therapeutics (KTTA)|CRGT (cortigent.com) - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Avenue Therapeutics, Inc. ATXI|Brainstorm Cell Therapeutics Inc. (BCLI) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Cara Therapeutics, Inc - Forvard P/S multiplikatori|Chromocell (CHRO) - Forvard narx/daromad multiplikatori|eliemtx.com (ELYM) - Narxning prognoz qilingan daromadga nisbati|ITCI (Intra-Cellular Therapies, Inc.) - Narxning prognoz qilingan daromadga nisbati|LBPH (Longboard Pharmaceuticals, Inc.) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Marinus Pharmaceuticals Inc MRNS|Narxning prognoz qilingan daromadga nisbati NKGen (NKGN)|NeuroBo Pharma - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Forvard P/S multiplikatori SAGE (Sage Therapeutics, Inc.)|synaptogen.com (SNPX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|TRVN: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx VIGL (Vigil Neuroscience)|WENA: Forvard P/S multiplikatori|CERE - Kapitalizatsiyaning kutilayotgan sotuvga nisbati
